Pfizer sells 7.3% stake in Haleon for $3.3bn
Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.
Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.
What's Your Reaction?
